We're an early team moving fast. Whether you invest, treat patients, or develop drugs, if longitudinal oncology is on your radar, reach out.
We're building the category and talking with partners who want to move early. Ask for the deck and the paper.
Talk to the foundersCancer centers and drug developers exploring serial-ctDNA trajectory modeling for trials and care.
Partner with usInterested in the problem, or just want to learn more about what we're building? Say hello.
Get in touch